Computational Drug Repurposing for The Management of Pathogenicity of Beta-Thalassemia. INTERNATIONAL JOURNAL OF APPLIED AND CLINICAL RESEARCH, v. 3, n. 2, p. 12–19, 3 Jun.2025.